Registration for a live webinar on 'Innovations in antibiotic discovery: combating resistant infections' is now open.
See webinar details
Dr. Michael Rafferty University of Kansas, USA
1 TalkBiography
Michael F. Rafferty is adjunct professor of medicinal chemistry at the University of Kansas. He trained at the University of Kansas and the National Institutes of Health before joining Parke-Davis Pharmaceuticals in 1984. His drug discovery research interests are CNS diseases and oncology, and the application of core enabling technologies... read moreto enhance productivity and reduce risks.
